HER 2 Win
7 October 2022 webinar

President: Paolo Marchetti


In the last year the HER2 positive disease has undergone to a real revolution.

The landscape has been radically changed with the advent of new therapeutic strategies.

The knowledge of the biological mechanisms underlying this tumour type plays a crucial role to identify the best therapeutic path for cancer patients.

In this course, opinion leaders provide a moment of scientific development and constructive dialogue able to ensure an event of high impact.